Novo Nordisk A/s v. Caraco Pharmaceutical Laboratories, Ltd.

NOTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
__________________________
NOVO NORDISK A/S AND NOVO NORDISK, INC.,
Plaintiffs-Appellants,
v.
CARACO PHARMACEUTICAL LABORATORIES,
LTD., AND SUN PHARMACEUTICAL
INDUSTRIES, LTD.,
Defendants-Appellees.
__________________________
2010-1001
__________________________
Appeal from the United States District Court for the
Eastern District of Michigan in case no. 2:05-CV-40188,
Judge Avern Cohn.
__________________________
ON MOTION
__________________________
ORDER
Novo Nordisk A/S et al. (Novo Nordisk) move for an
extension of time to respond to Caraco Pharmaceutical
Laboratories, Ltd. et al. (Caraco)’s motion to affirm the
injunction of the United States District Court for the
Eastern District of Michigan. Caraco opposes. Novo
Nordisk replies.
NOVO NORDISK v. CARACO PHARMA 2
The court notes that on April 17, 2012, the Supreme
Court of the United States in Caraco Pharm. Lab., Ltd. v.
Novo Nordisk A/S, 132 S. Ct. 1670 (2012) reversed the
judgment of this court and remanded the case for further
proceedings.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) This court’s opinion of April 14, 2010 is vacated,
the mandate of this court issued on August 5, 2010 is
recalled, and the appeal is reinstated.
(2) The motion is granted to the extent that Novo
Nordisk’s response is due May 24, 2012.
FOR THE COURT
May 23, 2012 /s/ Jan Horbaly
Date Jan Horbaly
Clerk
cc: Josh A. Krevitt, Esq.
James F. Hurst, Esq.